Glacier Peak Capital’s iShares Biotechnology ETF IBB Stock Holding History

Glacier Peak Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.05M	Buy	+10,548	New	+$1.1M	1.09%	35
2019 Q1	–	Sell	-19,781	Closed	-$1.91M	–	77
2018 Q4	$1.91M	Buy	+19,781	New	+$2.1M	1.76%	26
2018 Q3	–	Sell	-2,010	Closed	-$221K	–	48
2018 Q2	$221K	Sell	2,010 -54	-3%	-$5.78K	0.17%	42
2018 Q1	$220K	Buy	+2,064	New	+$229K	0.13%	50

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Glacier Peak Capital's IBB Position: Q3 2019 in Review

Glacier Peak Capital opened a new position in iShares Biotechnology ETF (IBB) in Q3 2019: 10,548 shares worth $1.05M. The stake represents 1.09% of the portfolio and ranks #35 among its holdings. This is a return to the name: Glacier Peak Capital previously reported a position in IBB as recently as Q4 2018.

Glacier Peak Capital first reported a position in IBB in Q1 2018 and has held it in 4 quarters since. The position peaked at $1.91M in Q4 2018. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Glacier Peak Capital held 10,548 shares of iShares Biotechnology ETF worth $1.05M as of Q3 2019.
iShares Biotechnology ETF was a new Glacier Peak Capital position in Q3 2019.
iShares Biotechnology ETF made up 1.09% of Glacier Peak Capital's portfolio in Q3 2019, its #35 holding.
Glacier Peak Capital first reported a position in iShares Biotechnology ETF in Q1 2018 and has held it in 4 quarters since.
Glacier Peak Capital's iShares Biotechnology ETF position peaked at $1.91M in Q4 2018.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Glacier Peak Capital's 13F filing for Q3 2019, filed 12 Nov 2019.